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Dernfalk J, Persson Waller K, Johannisson A: Commercially available antibodies
to human tumour necrosis factor-α tested for cross-reactivity with ovine and
bovine tumour necrosis factor-α using ﬂow cytometric assays. Acta vet. scand.
2004, 45, 99-107. – A thorough understanding of the immune system, including the role
of different cytokines, during inﬂammatory diseases in ruminants could lead to the de-
velopment of new diagnostic methods and treatments. Tumour necrosis factor-α (TNF-
α) is an important cytokine in the onset of the inﬂammatory responses. Unfortunately,
the number of studies on cytokines, like TNF-α, in ruminants is limited due to a lack of
species-speciﬁc reagents. As cytokines have remained rather conserved during evolu-
tion, cross-reactivity between animal species may occur. Therefore, the aim of the pre-
sent study was to investigate 5 commercially available antibodies against human TNF-
α for their ability to cross-react with ovine and/or bovine TNF-α, using a bead-based
ﬂow cytometric method. Two of the antibody clones (Mab 11 and 6401.1111) showed
cross reactivity with ovine recombinant TNF-α in concentrations above 2.5ng/ml. How-
ever, none of the antibodies detected TNF-α in bovine milk, or serum containing known
concentrations of bovine TNF-α, as earlier determined with ELISA. The results could
be due to inability of the antibodies to cross-react between species, but quenching of the
signal by matrix proteins might also have lowered the response.
cross-reactivity; particle based ﬂow cytometry; pro-inﬂammatory cytokines; rumi-
nants; bovine- ovine- human TNF-α. 
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Introduction
The inﬂammatory response during bacterial in-
fections in ruminants is mediated by pro-in-
ﬂammatory cytokines, such as tumour necrosis
factor-a (TNF-a) (Sordillo & Peel 1992). TNF-
α has an important role as a mediator of the in-
ﬂammatory response as it induces expression of
adhesion molecules on endothelial cells, acti-
vates neutrophils and macrophages, and in-
duces production of nitric oxide and comple-
ment factors (Tracey 2002,  Rainard et al.
2000). Quantitation of cytokines in biological
ﬂuids could be a useful tool in the diagnosis of
inﬂammatory conditions since cytokine pat-
terns give detailed information about the course
of an inﬂammation. Infectious diseases, like
mastitis, represent great health problems
among dairy cows and sheep. A thorough un-
derstanding of how the immune system acts
during such diseases could lead to the develop-
ment of new diagnostic methods and/or treat-ments. Therefore, the development of new tech-
niques for measuring ruminant cytokines is
warranted. 
Several methods have been developed for cy-
tokine detection, such as enzyme-linked im-
munosorbent assay (ELISA), enzyme-linked
immuno spot assay (ELISPOT), bioassays,
polymerase chain reaction (PCR) and intracel-
lular staining (Bienvenu et al. 2000). Recently,
multiplex cytokine assays have been developed,
which measure several cytokines simultane-
ously in the same sample. In a study by Carson
& Vignali (1999), 15 human cytokines were
measured simultaneously in the same sample
with a multiplex particle based ﬂow cytometric
method, the LabMAP™-assay (Luminex Cor-
poration, Austin, TX, USA). Simultaneous
quantiﬁcation of several substances in a sample
makes it possible to calculate the cytokine ratio.
An altered cytokine ratio in an individual is
considered a marker of disease state such as
asthma and atopy (Maggi 1998).
Studies on cytokines in ruminants are limited
by a lack of species-speciﬁc reagents. However,
as cytokines have remained conserved during
evolution, cross-reactivity between animal
species may occur. In support for this con-
tention, Pedersen et al. (2002) found that an an-
tibody against ovine TNF-α cross-reacted with
bovine and human TNF-α. To our knowledge,
no studies on cross-reactivity between antibod-
ies to human TNF-α and ovine and bovine cy-
tokines have been published. Therefore, the aim
of this study was to investigate the ability of a
number of commercially available antibodies to
human TNF-α to cross-react with ovine and/or
bovine TNF-α using particle based ﬂow cytom-
etry. The assays were performed using two dif-
ferent procedures. Procedure one is called the
LabMAP™-assay, where both coupling of anti-
bodies to microspheres and detection assays
were performed. The other is called the Fluo-
rokine® MAP-assay (R&D Systems, Minne-
apolis, MN, USA), where microspheres already
coupled with antibodies are used. 
Materials and methods
Antibodies, recombinant proteins and samples
The antibodies to human TNF-α used were all
commercially available (Table 1). Two clones of
recombinant human TNF-α (rhuTNF-α) were
used. One was purchased from Serotec Ltd
(Oxford, England) and the other was included
in the Fluorokine® MAP kit (R&D Systems).
Recombinant ovine TNF-α (rovTNF-α) used
was a kind gift from Dr. I. G. Colditz (CSIRO,
Armidale, Australia). 
Recombinant bovine TNF-a is not commer-
cially available. Therefore, bovine serum and
milk samples with known concentrations of
TNF-α were used as positive controls in this
study. Three bovine serum samples containing
14000, 15400 and 15600 pg TNF-α/ml, respec-
tively, were used as positive controls. The sam-
ples were a kind gift from Dr. C. Røntved, Dan-
ish Institute of Agricultural Sciences, Tjele,
Denmark, who earlier had measured the con-
centration of bovine TNF-α in the serum sam-
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Table 1. List of anti-human TNF-a antibodies used in this study. 
Capture antibodies Company Reporter antibodies
Mab1 BD Pharmingen (San Diego, CA, USA) Mab11
Mab11 BD Pharmingen  6401.1111
6401.1111 BD Biosciences (San Diego, CA, USA) Mab1
B-C7 Serotec (Oxford, England) Mab11 or 6401.1111
Polyclonal R&D Systems (Minneapolis, MN, USA) Mab 11 or 6401.1111ples using ELISA. The serum samples origi-
nated from blood collected from 3 Holstein-
Friesian cows that were experimentally infected
with different doses of Escherichia coli endo-
toxin lipolysaccharide (LPS) in vivo. The doses
used were: 0.25, 1 or 2 µg LPS/kg bodyweight.
Serum samples were maintained at -70°C for 6
months before use.  
Four bovine milk samples containing 2300,
3250, 13000 and 52000 pg TNF-α/ml, respec-
tively, were used as positive controls. Concen-
trations of TNF-α in the samples were earlier
determined with ELISA by Dr Bruckmaier,
Agrar TU, Munich, Germany. The milk sam-
ples were collected from 4 cows where acute
mastitis was experimentally induced with the
introduction of Staphylococcus aureus into the
udder (Grönlund et al. 2003). Milk samples
were maintained at -70°C for one year before
use.
Two bovine serum samples and 2 bovine milk
samples containing less than 100 pg/ml of
TNF-α, originating from the same studies as
the positive controls, were used as negative
controls in this study. In experiments using
rhuTNF-α and rovTNF-α, the buffer used was
phosphate buffered saline (PBS) which also
was used as a negative control.  
Reagents
Microspheres were purchased from Luminex
Corporation (Austin, TX, USA), human phyco-
erythrin (PE) -conjugated streptavidin from
Dako A/S (Copenhagen, Denmark), N-hydrox-
ysulfosuccinimide (Sulpho-NHS) and 1-ethyl-
3-(3-dimethylaminopropyl) carbodiimide hy-
drochloride (EDC) from Pierce Biotechnology
Inc. (Rockford, IL, USA), phosphate buffered
saline (PBS) without Ca2+and Mg2+ from the
National Veterinary Institute (SVA) (Uppsala,
Sweden), Tween 20 from Merck-Schuchardt
(Hohenbrunn, Germany) and Bovine Serum
Albumin (BSA) and morpholinoethanesulfonic
acid (MES) from Sigma Chemicals (St. Louis,
MS, USA). Finally, Fluorokine® MultiAnalyte
Proﬁling Kit (Fluorokine® MAP) was obtained
from R&D Systems (Minneapolis, MN, USA).
The Luminex 100™ and Luminex XYP™ plat-
form were purchased from Luminex Corpora-
tion.
Method optimization
Preliminary studies for the LabMAP™-assay
were performed to determine the optimal detec-
tion system, which involved the assessement of
different concentrations of capture and reporter
antibodies, incubation times and temperatures.
Two detection systems were tested, one direct
method where the reporter antibody was PE-
conjugated, and one indirect method where a
biotinylated reporter antibody was detected by
PE-conjugated streptavidin. In assays on
rovTNF-α, best results were achieved by indi-
rect detection, whereas the best detection sys-
tem for rhuTNF-α was the direct detection sys-
tem. Seven different concentrations of the
different capture antibodies (5mg/ml, 0.5mg/
ml, 50µg/ml, 5µg/ml, 100ng/ml, 50ng/ml and
10ng/ml) and reporter antibodies (3.2µg/ml,
1.6µg/ml, 800ng/ml, 400ng/ml, 320ng/ml,
200ng/ml, and 100ng/ml) were tested. Varying
incubation times and temperatures were used
for the incubation steps with antibodies (20
minutes at room temperature (RT) and 37°C,
45 min at RT, 1 h at RT, 1.5 h at RT, 2 h at RT
and 37°C and overnight at RT). The best proce-
dures for rhuTNF-α and rovTNF-α, with re-
spect to signal intensity and background, are
described below.  
Coupling of monoclonal antibodies to 
microspheres
Coupling of antibodies to Luminex micro-
spheres was performed in 1.7 ml eppendorf
tubes (AB Göteborgs Termometerfabrik, Väs-
tra Frölunda, Sweden) according to the manu-
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Training Material). Brieﬂy, about 600000 mi-
crospheres were dissolved and washed twice
with 100µl activation buffer (0.1 M sodium
phosphate buffer, pH 6.2) before resuspension
in 80µl activation buffer. Ten µl each of freshly
prepared 50 mg/ml sulfo-NHS and 50 mg/ml
EDC solutions were added to the suspension.
The microsphere solution was incubated for 20
min in the dark at RT. The activated micro-
spheres were washed twice with 100µl coupling
buffer (0.1M MES diluted in dH2O) before
500µl of TNF-α-antibody (0.5mg/ml) was
added and the mixture was rotated for 2 h in the
dark at RT (Fischer Hematology Mixer, Fisher
Scientiﬁc International Inc., Hampton, NH,
USA). After incubation the microspheres were
washed twice with washing buffer (PBS with
0.05% Tween) and resuspended in PBS with
0.02% Tween (PBST) and 1mg/ml bovine se-
rum albumin. The microspheres with attached
antibodies were kept at 2-8ºC, protected from
light for at the longest for 14 days before use.   
Cytokine assay using LabMAP™ 
RhuTNF-α (Serotec Ltd) or rovTNF-α was di-
luted in PBST to create appropriate standard
curves. Bovine serum and milk samples were
diluted 1:4 in PBST. Ninety ml cytokine solu-
tion, bovine serum or milk sample, was mixed
with 3µl antibody-coupled microspheres, con-
taining approximately 10 000 beads, and incu-
bated for 20 min in the dark at RT. The mixture
was subsequently washed twice with PBST.
Forty ml biotinylated (5pg/ml) reporter anti-
body was added to rhuTNF-α samples whereas
a PE-conjugated (0.3pg/ml) reporter antibody
was added to the rovTNF-α samples. To milk
and serum samples, either biotinylated reporter
antibodies or PE-conjugated antibodies were
added. All samples were incubated for 30 min
in the dark at room temperature. After the incu-
bation, rovTNF-α, milk and serum samples
with PE-conjugated antibodies were washed
twice with PBST and resuspended in 300ml
PBS. Thereafter, they were transferred to 96-
well microtiter plates (Göteborgs Termometer-
fabrik) and analysed on the Luminex 100™
analyser (Luminex Corp.). The rhuTNF-α,
milk and serum samples with biotinylated re-
porter antibodies were washed twice with 100µl
PBST. Then 40ml streptavidin-PE, diluted
1:100 in PBST, was added and the samples
were incubated for 20 min protected from light
at RT. Samples were then washed twice with
PBST, resuspended in 300µl PBS and analysed
on the Luminex 100™ analyser. All experi-
ments were performed in duplicates or tripli-
cates and repeated at least 2 times.
Cytokine assay using Fluorokine® MAP
The cytokine assay was performed according to
manufacturer's instructions (R&D, Minneapo-
lis, MN, USA). Brieﬂy, RhuTNF-α (Serotec
Ltd and R&D Systems) or rovTNF-α was di-
luted in PBST to appropriate standard curves.
Bovine serum and milk samples were diluted
1:4 in PBST. A recovery experiment was con-
ducted to verify if the assay could measure cy-
tokines added to the milk or serum matrix. Du-
plicates of each sample were prepared and to
one of the duplicates 50 µl of 2ng/ml rhuTNF-
α was added. Fifty ml microsphere mixture was
added to 50µl standard, or sample, and was in-
cubated in the dark at RT on rotation (Fischer
Hematology Mixer, Fisher Scientiﬁc Interna-
tional Inc.) for 2 h. The microspheres were
washed 3 times with 100µl washing buffer after
which 100µl of conjugate cocktail was added
and the solution was incubated for another 2 h.
After incubation, the microspheres were
washed 3 times with washing buffer, resus-
pended in 100µl washing buffer and analysed in
the Luminex 100™ analyser. All experiments
were performed in duplicates or triplicates and
repeated at least 2 times.
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Figure 1. Standard curve of recombinant ovine TNF-α (--) analysed with the LabMAP™-assay, using the
antibodies to human TNF-a named Mab11 and 6401.1111. The curve is presented as mean ﬂuorescence inten-
sity versus concentration of standard. Results represent the mean (SD) of 4 standards performed in duplicate in
2 different experiments. The limit of detection for the assay is shown as a dotted line and was deﬁned as the con-
centration corresponding to the signal 3 SD above the mean ﬂuorescence of 6 samples without TNF-α. The mean
ﬂuorescence of the samples without TNF-α is shown as a dashed line.
Figure 2. Standard curves of 2 different recombinant human TNF-α analysed with the Fluorokine® MAP-kit,
TNF-α from Serotec Ltd (--) and TNF-α from R&D Systems (--). Curves are presented as mean ﬂuores-
cence intensity versus concentration of standards. Results represent the mean (SD) of 4 standards performed in
duplicate in 2 different experiments. The limit of detection for the assay is shown as a dotted line and was de-
ﬁned as the concentration corresponding to the signal 3 SD above the mean ﬂuorescence of 4 samples without
TNF-α. The mean ﬂuorescence of the samples without TNF-α is shown as a dashed line. Results
Cytokine assay using LabMAP™
Results from the cytokine assay by Luminex
showed that all antibodies investigated detected
rhuTNF-α(data not shown). In addition, the an-
tibody combination Mab11 and 6401.1111
showed cross-reactivity with rovTNF-α when
the cytokine concentration was above 2.5ng/ml
(Fig. 1). However, none of the 7 different anti-
body combinations tested detected TNF-α in
the bovine serum or milk samples (data not
shown). 
Cytokine assay using Fluorokine® MAP
The limit of detection of the Fluorokine®MAP-
kit for rhuTNF-a was approximately 4pg/ml
(Fig. 2). The kit detected both rhuTNF-α from
R&D Systems, and rhuTNF-α from Serotec
Ltd. The kit did not detect rovTNF-α (data not
shown) nor bovine TNF-α in the serum or milk
samples (Figs. 3 and 4). The recovery test
showed that the kit detected rhuTNF-α when
50µl of 2ng/ml rhuTNF-α was added to the
milk or serum samples (Figs. 3 and 4). The
magnitude of the signals was however weaker
in milk and serum compared with values
achieved when measuring the same amount of
rhuTNF-α in buffer. The mean percent recover-
ies in serum and milk, based on results from du-
plicate samples from two separate experiments,
were 36.4 ± 1.6% and 59.8 ± 2.0%, respec-
tively. When calculating the results, the mean
ﬂuorescence intensity from the experiments
with rhuTNF-a in buffer was set to 100%.
Thereafter, the mean ﬂuorescence intensity
from the experiments with rhuTNF-α serum
and milk were compared to the experiments in
buffer and the results are shown as percent of
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Figure 3. Mean ﬂuorescence intensity from 3 bovine serum samples containing 14000, 15400 and 15600 pg
TNF-α/ml, respectively, and 2 pooled serum samples not containing any TNF-α (0 pg/ml), as previously deter-
mined with ELISA. Concentrations of bovine TNF-α in the samples were determined with Fluorokine® MAP-
kit, before (black bar) and after (grey bar) addition of 50 µl 2ng/ml recombinant human TNF-α. The dashed line
marks the ﬂuorescence of microspheres incubated with buffer only, whereas the solid line marks the ﬂuorescence
of microspheres incubated with buffer containing 50µl 2ng/ml recombinant human TNF-α. rhuTNF-α in serum/milk ± standard deviation. 
Discussion
All antibodies to human TNF-α investigated
with the LabMAP™-assay in this study could
detect rhuTNF-α. Those results indicate that
the technique worked satisfactory. The anti-
bodies against human TNF-α named Mab11
and 6401.1111 in combination also detected
rovTNF-α in concentrations above 2.5ng/ml.
However, this detection level is not satisfactory
given that cytokines are very powerful signal
molecules that give effects at low concentra-
tions (Kelso 1998). 
None of the antibodies against human TNF-α
tested with the LabMAP™-assay could detect
TNF-α in bovine serum or milk samples with
known TNF-α concentrations. These results
could be explained by the inability of antibod-
ies to cross-react between species, or that the
ﬂuorescent signal was somehow quenched. Re-
sults of Pedersen et al. (2002) suggest that the
TNF-α protein has remained conserved during
evolution since other studies have shown that at
least 60% amino acid homology is required be-
tween proteins for cross-reactivity to occur
(Scheerlinck 1999). An 84% homogeneity is
found between human and bovine TNF-α while
ovine and bovine TNF-α shows more than 90%
homogeneity when performing a genetic se-
quence comparison (http://www.ncbi.nlm.nih.
gov/BLAST/). This indicates that human,
bovine and ovine TNF-a have a high degree of
similarity. However, our results do not com-
pletely support that theory, as none of the hu-
man antibodies tested in this study detected
TNF-α in bovine samples and only one pair of
antibodies detected rovTNF-α using the
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Figure 4. Mean ﬂuorescence intensity from bovine milk samples containing 2300, 3250, 13000 and 52000 pg
TNF-α/ml respectively and 2 pooled milk samples not containing any TNF-α (0 pg/ml), as previously deter-
mined with ELISA. Concentrations of bovine TNF-α were determined with Fluorokine® MAP-kit, before (black
bar) and after (grey bar) addition of 50 µl 2ng/ml recombinant human TNF-α. The dashed line marks the ﬂuo-
rescence of microspheres incubated with buffer only, whereas the solid line marks the ﬂuorescence of micro-
spheres incubated with buffer containing 50 µl 2ng/ml recombinant human TNF-α. LabMAP™-assay. 
Both rhuTNF-α used in this study could be de-
tected with the Fluorokine® MAP kit, and con-
centrations of ≥4 pg/ml of rhuTNF-α could be
quantiﬁed. This detection limit could be com-
pared to the quite high concentration of
2.5ng/ml that was required to achieve a signal
when measuring rovTNF-α with the Lab
MAP™-assay. However, the Fluorokine® MAP
kit could not detect any rovTNF-α or bovine
TNF-a in the serum and milk samples.
The recovery experiment where 50µl 2ng/ml
rhuTNF-α was added to bovine milk and serum
showed that the Fluorokine® MAP kit detected
rhuTNF-α to a lower degree when added to
bovine milk, or serum samples compared with
quantiﬁcations in buffer, indicating a moderate
quenching effect of the milk and serum. Both
milk and serum are complex matrices that con-
tain proteins and cells that may quench the sig-
nal from a ﬂuorescent reporter antibody and
thereby disturb the cytokine analysis (Mire-
Sluis et. al. 1995, Selby 1999). Such an effect
will not preclude cytokine detection when a
high protein concentration is measured, but
hampers the analysis when the concentration of
protein is low. This experiment needs to be re-
peated adding varying concentrations of cy-
tokine to normal bovine serum and milk since
recovery experiments can show diverging re-
sults depending on the amount of cytokine
added (Cook et. al. 2001).
In conclusion, our results indicate poor cross-
reactivity between ovine/bovine TNF-α and the
antibodies against human TNF-α used in this
study making these antibodies unsuitable for
further use in ovine/bovine immunoassays.
However, the LabMAP™- and Fluorokine®
MAP-assays may be valuable tools in studies
on the roles of ovine and bovine cytokines dur-
ing different inﬂammatory reactions.
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Sammanfattning
Kommersiellt tillgängliga antikroppar mot human
Tumour Necrosis Factor-α testade för korsreaktivitet
med ovin och bovin Tumour Necrosis Factor-α med
hjälp av ﬂödescytometriska analyser.
En grundlig förståelse för immunsystemet inklusive
betydelsen av olika cytokiner vid inﬂammationssjuk-
domar hos idisslare kan leda till utveckling av nya di-
agnostiska metoder och behandlingar. En viktig cyto-
kin i den tidiga inﬂammationsreaktionen är tumour
necrosis factor-α (TNF-α). Tyvärr begränsas ofta
studier rörande cytokiner som TNF-αhos idisslare av
brist på artspeciﬁka reagenser. Eftersom cytokiner
har visats vara konserverade genom evolutionen fö-
rekommer korsreaktivitet mellan arter. Målet med
den här studien var därför att med hjälp av partikel-
baserad ﬂödescytometri undersöka om 5 kommersi-
ellt tillgängliga antikroppar mot humant TNF-α
kunde korsreagera med ovint och/eller bovint TNF-a.
Två av antikroppsklonerna (Mab 11 och 6401.1111)
korsreagerade med ovint rekombinant TNF-α vid
koncentrationer över 2,5 ng/ml. Ingen av de under-
sökta antikropparna detekterade dock TNF-α i bo-
vina serum- och mjölkprov med kända koncentratio-
ner av TNF-α tidigare bestämda med ELISA-analys.
Resultaten kan tyda på en oförmåga hos antikrop-
parna att korsreagera mellan arter men matrixprotei-
ner kan också ha minskat signalens magnitud.
Human ovin and bovine tumour Necrosis factor-α 107
Acta vet. scand. vol. 45 no. 1-2, 2004
(Received September 19, 2004; accepted January 13, 2004).
Reprints may be obtained from: Johanna Dernfalk, Department of Anatomy and Physiology, Swedish University
of Agricultural Sciences, P.O. Box 7011, SE-750 07, Uppsala, Sweden. E-mail address: Johanna.Dernfalk@afys.
slu.se tel: +46-18-672149, fax: +46-18-672852.